The combination with photothermal therapy (PTT) and site-directed drug delivery mediated by PLGA particles accomplished enhanced anti-tumor activity via effective anti-PD1 mAb release and infiltration of CD8+ T cells into the tumor. The gene discussed is CD8A; the disease is neoplasm.